U.S. market Closed. Opens in 17 hours 2 minutes

MIRA | MIRA Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue8.53MN/AN/AN/A
Gross Profit-8.53MN/AN/AN/A
Operating Expenses8.53M7.05M2.15M67.63K
Selling, General & Admin6.95M2.99M770.12K52.98K
Research & Development1.57M2.35M684.45K14.65K
Other Operating ExpensesN/A-1.70M-697.60KN/A
Operating Income-8.53M-7.05M-2.15M-67.63K
Other Expenses / Income-3.46M-10.25K-24.37K-363.00
Before Tax Income-11.98M-7.06M-2.18M-67.99K
Income Tax Expenses-8.53K-7.05K-2.15K-202.00
Net Income-11.98M-7.06M-2.18M-67.99K
Interest Expenses-3.46M10.25K24.37K364.00
Basic Shares Outstanding18.57M14.75M14.75M14.75M
Diluted Shares Outstanding18.57M14.75M14.75M14.75M
EBITDA-8.53M-7.05M-2.15M-67.63K
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-15.45M-7.05M-2.15M-67.83K
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙